Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NEUROINNOVATECH ApS
APS
Active
Advertising protection
CVR 44482096
Vandtårnsvej 62A, 2860
Søborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
— employees
www.neuroinnovatech.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
NEUROINNOVATECH ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-220
Staff expenses
-0
EBITDA
-220
Depreciation & amort.
-17
EBIT
-237
Net financials
0
Profit before tax
-237
Tax
-0
Net profit
-237
Balance sheet
DKK thousands
Item
2025
Total assets
2.384
Equity
923
Long-term debt
0
Short-term debt
1.461
Total debt
1.461
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-21999300.0%
This company
2025
2025
Equity ratio
38.7%
This company
38.2%
Market median
+1% vs market
2025
2025
Return on equity
-25.6%
This company
18.4%
Market median
-239% vs market
2025
2025
Net profit margin (of gross profit)
-23666100.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.09×
This company
2025
2025
Debt / equity
1.58×
This company
0.62×
Market median
-155% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2023-11-28 – 2025-04-30
View
PDF
More on NEUROINNOVATECH ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
